Comprehensive epidemiology of melanoma at all sites: insights from Japan's National Cancer Registry, 2016-2017.

IF 2.4 3区 医学 Q3 ONCOLOGY International Journal of Clinical Oncology Pub Date : 2025-02-01 Epub Date: 2025-01-03 DOI:10.1007/s10147-024-02675-0
Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Maiko Fujimori, Yosuke Uchitomi, Takahiro Higashi, Tomoyuki Satake, Chigusa Morizane, Naoya Yamazaki, Akira Kawai
{"title":"Comprehensive epidemiology of melanoma at all sites: insights from Japan's National Cancer Registry, 2016-2017.","authors":"Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Maiko Fujimori, Yosuke Uchitomi, Takahiro Higashi, Tomoyuki Satake, Chigusa Morizane, Naoya Yamazaki, Akira Kawai","doi":"10.1007/s10147-024-02675-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Melanoma is a highly malignant cancer responsible for 55 000 deaths worldwide annually. Despite its severity, its epidemiology in Japan remains understudied owing to its rarity among Asians. This study aimed to determine the incidence of melanoma in Japan using data from the National Cancer Registry.</p><p><strong>Methods: </strong>We analyzed data from patients diagnosed with melanoma in 2016 and 2017, classifying cases according to subtype using the World Health Organization (WHO) and other tumor classifications. Tumor incidence was calculated as the number of new cases divided by the corresponding population per year.</p><p><strong>Results: </strong>A total of 6176 patients were included in the study. The subtypes were distributed as follows: cutaneous (76.2%), mucosal (19.6%), uveal (2.7%), and neural organ/unknown primary melanoma (1.3%). The overall age-adjusted incidence of melanoma was 2.57 per 100 000 persons in the Japanese and 1.15 per 100 000 persons in the WHO population models.</p><p><strong>Conclusions: </strong>This study provided comprehensive epidemiological data on melanoma in Japan using population-based registry data, highlighting the relatively low incidence of melanoma compared with that worldwide and emphasizing the need for further research into its unique epidemiology in Asian populations.</p>","PeriodicalId":13869,"journal":{"name":"International Journal of Clinical Oncology","volume":" ","pages":"194-198"},"PeriodicalIF":2.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10147-024-02675-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Melanoma is a highly malignant cancer responsible for 55 000 deaths worldwide annually. Despite its severity, its epidemiology in Japan remains understudied owing to its rarity among Asians. This study aimed to determine the incidence of melanoma in Japan using data from the National Cancer Registry.

Methods: We analyzed data from patients diagnosed with melanoma in 2016 and 2017, classifying cases according to subtype using the World Health Organization (WHO) and other tumor classifications. Tumor incidence was calculated as the number of new cases divided by the corresponding population per year.

Results: A total of 6176 patients were included in the study. The subtypes were distributed as follows: cutaneous (76.2%), mucosal (19.6%), uveal (2.7%), and neural organ/unknown primary melanoma (1.3%). The overall age-adjusted incidence of melanoma was 2.57 per 100 000 persons in the Japanese and 1.15 per 100 000 persons in the WHO population models.

Conclusions: This study provided comprehensive epidemiological data on melanoma in Japan using population-based registry data, highlighting the relatively low incidence of melanoma compared with that worldwide and emphasizing the need for further research into its unique epidemiology in Asian populations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
所有地点黑色素瘤的综合流行病学:来自日本国家癌症登记处的见解,2016-2017。
背景:黑色素瘤是一种高度恶性癌症,每年在全世界造成55000人死亡。尽管它很严重,但由于它在亚洲人中罕见,日本的流行病学研究仍然不足。这项研究旨在利用国家癌症登记处的数据确定日本黑色素瘤的发病率。方法:对2016年和2017年诊断为黑色素瘤的患者数据进行分析,使用世界卫生组织(WHO)和其他肿瘤分类,根据亚型对病例进行分类。肿瘤发病率计算为每年新发病例数除以相应人群。结果:共纳入6176例患者。亚型分布如下:皮肤黑色素瘤(76.2%)、粘膜黑色素瘤(19.6%)、葡萄膜黑色素瘤(2.7%)和神经器官/未知原发性黑色素瘤(1.3%)。在日本,经年龄调整的黑色素瘤总发病率为每10万人2.57例,在世界卫生组织人口模型中为每10万人1.15例。结论:本研究利用基于人口的登记数据提供了日本黑色素瘤的全面流行病学数据,强调了与全球相比,日本黑色素瘤的发病率相对较低,并强调了进一步研究其在亚洲人群中独特流行病学的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.80
自引率
3.00%
发文量
175
审稿时长
2 months
期刊介绍: The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
期刊最新文献
Immunotherapy for endometrial cancer. Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors. Impact of presurgical systemic therapy on perioperative outcomes of renal cell carcinoma with inferior vena cava tumor thrombus. Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer. Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1